Agarwal Arjuninsider trades
In SEC Form 4 filings, Agarwal Arjun is listed as Senior Vice President, Finance of Oruka Therapeutics, Inc. (ORKA). In the last 90 days, Agarwal Arjun sold $1.78M of Oruka Therapeutics, Inc. (ORKA) on the open market and bought none. All 10 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Senior Vice President, Finance | 18 | Oct 13 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | M | 8,541 | $12.50 | $106,763 | 22,760 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | M | 1,458 | $34.39 | $50,141 | 24,218 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | S | 5,741 | $80.03 | Sale −$459,453 | 18,477 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | S | 2,100 | $80.76 | Sale −$169,596 | 16,377 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | S | 1,958 | $81.86 | Sale −$160,272 | 14,419 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | S | 200 | $82.84 | Sale −$16,567 | 14,219 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | M · derivative | 8,541 | $12.50 | $106,763 | 76,376 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 12 | Oct 13 | M · derivative | 1,458 | $34.39 | $50,141 | 56,875 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 21 | Sep 21 | S | 533 | $95.75 | Sale −$51,035 | 14,219 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 560 | $95.71 | Sale −$53,598 | 14,752 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | M | 8,000 | $12.50 | $100,000 | 23,312 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | M | 1,459 | $34.39 | $50,175 | 24,771 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | S | 3,000 | $91.11 | Sale −$273,322 | 21,771 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | S | 4,051 | $92.41 | Sale −$374,367 | 17,720 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | S | 2,208 | $93.26 | Sale −$205,921 | 15,512 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | S | 200 | $94.02 | Sale −$18,803 | 15,312 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | M · derivative | 8,000 | $12.50 | $100,000 | 84,917 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 11 | Sep 15 | M · derivative | 1,459 | $34.39 | $50,175 | 58,333 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.